Melatonin, Oxidative Stress, and the Aging Brain

Abstract

The changes associated with brain aging are discussed with emphasis on altered oxidative and inflammatory events and on mitochondrial dysfunction. Many of these changes are exacerbated in a variety of age-related neurologic diseases. This commonality has led to the idea that similar therapeutic approaches may be used in the treatment of several apparently unrelated neurodegenerative disorders. When aspects of these diseases are modeled in experimental animals and cell lines, the application of melatonin has been reported to be advantageous. The means by which melatonin can be protective probably is mediated by way of activation of melatonin receptors, of which several subtypes can be identified. This can initiate a sequence of intracellular signaling events and by activation of transcription factors lead to altered gene expression. The culmination of this cascade can lead to increased levels of antioxidant enzymes and depressed levels of inflammation. Melatonin may be useful both in the retardation of nonpathologic brain aging and in the amelioration of chronic brain disease associated with aging. The inexpensive nature and ready availability of melatonin together with its very low toxicity reinforce the need to place the beneficial properties of this agent on a firmer basis.

Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration

“…In consequence, the aging brain can gradually accumulate evidence of prior insults until a permanently damaging degree of inflammatory activity is reached and maintained. These findings offer a clue as to why the aged brain shows evidence of permanent inflammation with age (Bondy and Sharman, 2010). The responses to short-lived inflammatory events such as infections, which involve the whole body, may be prolonged in the CNS for an extended period (Shi et al, 2003;Bilbo et al, 2005;Galic et al, 2008).…”

Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer

“…Interestingly, circadian rhythm dysfunction during cognitive loss and aging has been tied to the induction of autophagy (61). Studies with Drosophila show that the accumulation of neural aggregates observed with aging is associated with a reduction in the autophagy pathway.…”

Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors

“…Circadian rhythm dysfunction during cognitive loss and aging can be associated with autophagy induction (121). In animal models of AD, a basal circadian rhythm that controls macroautophagy may be necessary to limit cognitive decline and Aβ deposition (122).…”